Finland - finsk - Fimea (Suomen lääkevirasto)

benzon pharma a/s - ibuprofenum - depottabletti - 600 mg - ibuprofeeni

Irland - engelsk - HPRA (Health Products Regulatory Authority)

a/s alfred benzon - ibuprofen - tablets - 200 milligram

Irland - engelsk - HPRA (Health Products Regulatory Authority)

a/s alfred benzon - ibuprofen - tablets - 400 milligram

Irland - engelsk - HPRA (Health Products Regulatory Authority)

a/s alfred benzon - ibuprofen - tablets - 600 milligram

Sverige - svensk - Läkemedelsverket (Medical Products Agency)

takeda pharma ab - ibuprofen - oral suspension - 20 mg/ml - natriummetylparahydroxibensoat hjälpämne; natriumpropylparahydroxibensoat hjälpämne; ibuprofen 20 mg aktiv substans; glycerol hjälpämne; maltitol, flytande hjälpämne - ibuprofen

Sverige - svensk - Läkemedelsverket (Medical Products Agency)

orifarm healthcare a/s - ibuprofen - kapsel, mjuk - 400 mg - sorbitol hjälpämne; ibuprofen 400 mg aktiv substans

Filippinene - engelsk - FDA (Food And Drug Administration)

n/a; importer: zydus healthcare philippines inc.; distributor: zydus healthcare philippines inc. - sitagliptin (as phosphate) - film coated tablet - 100 mg

Filippinene - engelsk - FDA (Food And Drug Administration)

zydus healthcare philippines inc.; distributor: zydus healthcare philippines inc. - sitagliptin - film coated tablet - 50 mg

Den europeiske union - engelsk - EMA (European Medicines Agency)

merck sharp and dohme b.v - sitagliptin, metformin hydrochloride - diabetes mellitus, type 2 - drugs used in diabetes - for patients with type-2 diabetes mellitus:efficib is indicated as an adjunct to diet and exercise to improve glycaemic control in patients inadequately controlled on their maximal tolerated dose of metformin alone or those already being treated with the combination of sitagliptin and metformin.efficib is indicated in combination with a sulphonylurea (i.e. triple combination therapy) as an adjunct to diet and exercise in patients inadequately controlled on their maximal tolerated dose of metformin and a sulphonylurea.efficib is indicated as triple combination therapy with a ppar agonist (i.e. a thiazolidinedione) as an adjunct to diet and exercise in patients inadequately controlled on their maximal tolerated dose of metformin and a ppar agonist.efficib is also indicated as add on to insulin (i.e., triple combination therapy) as an adjunct to diet and exercise to improve glycaemic control in patients when stable dosage of insulin and metformin alone do not provide adequate glycaemic control.

Den europeiske union - engelsk - EMA (European Medicines Agency)

merck sharp & dohme b.v. - sitagliptin, metformin hydrochloride - diabetes mellitus, type 2 - drugs used in diabetes - for patients with type 2 diabetes mellitus:janumet is indicated as an adjunct to diet and exercise to improve glycaemic control in patients inadequately controlled on their maximal tolerated dose of metformin alone or those already being treated with the combination of sitagliptin and metformin.janumet is indicated in combination with a sulphonylurea (i.e., triple combination therapy) as an adjunct to diet and exercise in patients inadequately controlled on their maximal tolerated dose of metformin and a sulphonylurea.janumet is indicated as triple combination therapy with a ppar  agonist (i.e., a thiazolidinedione) as an adjunct to diet and exercise in patients inadequately controlled on their maximal tolerated dose of metformin and a ppar  agonist.janumet is also indicated as add on to insulin (i.e., triple combination therapy) as an adjunct to diet and exercise to improve glycaemic control in patients when stable dosage of insulin and metformin alone do not provide adequate glycaemic control.